Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 14, 2024.
All times in Eastern Daylight Time.
-
Medical Robotics and Computer-assisted Surgery Global Markets Report 2020-2023 & 2024-2028 Featuring Cyberdyne, Ekso Bionics, Intuitive Surgical Operations, Lifeward, Medtronic, Stryker, Zimmer Biomet - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Medical Robotics and Computer-assisted Surgery: The Global Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global market for medical ... more »
-
Factual Data Announces Reno D’Water as PresidentPITTSBURGH--(BUSINESS WIRE)--Factual Data®, a leading provider of credit and verification services to the lending industry, today announced Reno D’Water has been named president. In his new role, M... more »
-
Pink Lipsticks and Green Thumbs: Mary Kay Inc. Celebrates 60 Years of Sustainable Beauty With Special Tree Planting Event in LewisvilleDALLAS--(BUSINESS WIRE)--Mary Kay Inc., a corporate leader in global sustainability, is strengthening its roots in Lewisville. On May 10, the company partnered with the Arbor Day Foundation and Kee... more »
-
Medincell Provides Update on Phase 3 mdc-CWM Clinical TrialMONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL) today announced that the Phase 3 trial for F14 (mdc-CWM) being conducted by Arthritis Innovation Corporation (AIC) did... more »
-
Immune-Onc Therapeutics Announces Presentation of IO-202 Phase 1b Interim Data of Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Association (EHA) Annual CongressPALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Announces IO-202 CMML Interim Data at EHA2024 more »
-
BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for br... more »
-
BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le dévelop... more »
-
FMI Launches 2024 U.S. Grocery Shopper Trends Series: How Consumers Are Finding Value at the Grocery StoreARLINGTON, Va.--(BUSINESS WIRE)--Shoppers enjoy food shopping as much as ever, according to the latest annual survey by FMI – The Food Industry Association. more »
-
WHOOP、 クリスティアーノ・ロナウドとのグローバル・パートナーシップを発表ボストン--(BUSINESS WIRE)--(ビジネスワイヤ) -- ヒューマン・パフォーマンス企業のWHOOPは、伝説のサッカー・アイコンであるクリスティアーノ ・ロナウドを公式グローバル・アンバサダー兼投資家として迎えることを発表しました。これは、ロナウドにとってこれまでで最も重要な投資の一つです。ロナウドは、パトリック・マホームズ、マイケル・フェルプス、イーライ・マニング、ローリー・... more »
-
Medincell fait le point sur l’essai clinique de phase 3 de mdc-CWMMONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL) annonce aujourd'hui que l'essai de phase 3 évaluant F14 (mdc-CWM), conduit par Arthritis Innovation Corporation (AIC),... more »
-
ADOCIA Reports First Quarter 2024 Financial Results and Provides a Business UpdateLYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therap... more »
-
DENVER--(BUSINESS WIRE)--Today at Xperience 2024 — the customer experience (CX) event of the year — Genesys® unveiled multiple innovations to accelerate the impact of AI, empowering organizations t... more »
-
BOSTON--(BUSINESS WIRE)--Aliro won a Publisher’s Choice Award for its leading secure networking solution from Cyber Defense Magazine (CDM). more »
-
ADOCIA publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activitésLYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solut... more »
-
Ever.green Brings Additionality to the Energy Sector via High-Impact REC ContractsSEATTLE--(BUSINESS WIRE)--Ever.green has released a whitepaper detailing a new approach to procuring RECs that can address the urgent need to accelerate the energy transition. more »